Patient organizations and advocacy — asthma¶
Last verified from official sites: 2026-08-30.
Quick map¶
| Organization | Region | Patient-facing offer | Voice / advocacy mechanism |
|---|---|---|---|
| Asthma Australia | Australia | Asthma educators, information line, action-plan and community resources | Consumer Advisory Council, Asthma Champions, co-design, research priorities |
| Asthma + Lung UK | United Kingdom | Helpline, support groups, practical information | Story hub, severe-asthma lived-experience work, policy campaigning |
| Asthma Canada | Canada | Bilingual educator helpline, action-plan and self-management resources | Community stories, patient-developed rights and self-advocacy resources |
| Allergy & Asthma Network | United States | Patient education, outreach, study-finding resources | Patient Advocacy Leadership Initiative and legislative advocacy |
| Global Allergy & Airways Patient Platform (GAAPP) | Global | Multilingual asthma and severe-asthma resources | Member-organization network and multi-country patient campaigns |
Australia¶
Asthma Australia¶
- Role: national asthma charity whose current programme explicitly places lived experience at the centre of service design and research priority-setting.
- Patient support: the 1800 ASTHMA information service connects people and carers with asthma educators; the organization publishes action-plan, inhaler, trigger, school, emergency and severe-asthma resources.
- Participation infrastructure: its Consumer Advisory Council and Asthma Champions programme give people with asthma recurring roles in programme design, public communication and advocacy rather than treating stories as one-off testimonials.
- Research: stated priorities include childhood prevention and remission, carer support, severe disease, irreversible lung damage and equitable participation.
- Why it matters here: its public co-design report identifies validation, reassurance, understandable communication, checking comprehension, medication habits, timely care and partnership as “moments that matter.” These priorities align with qualitative evidence on treatment beliefs and relational continuity.
- Sources: QUM in CAD: lessons from lived experience; Faces of Asthma; research areas (accessed 2026-08-30).
United Kingdom¶
Asthma + Lung UK¶
- Role: lung-health charity covering asthma alongside other respiratory diseases.
- Patient support: helpline, community support groups, health information and practical guidance across diagnosis, medicines, attacks, work and daily life.
- Voice: a public “Your stories” hub includes experiences of hospitalization, biologic treatment, school, work, travel, pollution, recovery and bereavement. The stories demonstrate heterogeneity; they are not a representative sample.
- Advocacy: the organization uses lived experience in campaigns on air quality, access, respiratory services and severe asthma.
- Why it matters here: severe-asthma testimony repeatedly describes fear, isolation and a life organized around uncertain breathing; published qualitative studies independently report the same domains.
- Sources: Your stories; severe-asthma lived-experience report (accessed 2026-08-30).
Canada¶
Asthma Canada¶
- Role: national patient-driven charity focused on asthma education, support, research and advocacy.
- Patient support: a bilingual Asthma & Allergy HelpLine staffed by certified respiratory educators; action-plan, trigger, attack, exercise, air-quality, severe-asthma and older-adult resources.
- Voice: a public community-story hub covers childhood and adult disease, carers, diagnostic delay, severe asthma and comorbidity. A national survey and the Severe Asthma Canadian Patient Journey are used to identify social, financial and healthcare burdens.
- Advocacy: patient-developed resources include a bill of rights, a severe-asthma charter and a self-advocacy guide focused on shared goals, asking questions, workplace/school support and healthcare navigation.
- Sources: living with asthma; self-advocacy resources; community stories; living with severe asthma (accessed 2026-08-30).
United States¶
Allergy & Asthma Network¶
- Role: national patient education and advocacy organization spanning asthma, allergy and related conditions.
- Patient support: multi-channel educational resources, community outreach and study-finding support.
- Advocacy: the Patient Advocacy Leadership Initiative trains patients and carers in policymaking, communication and storytelling. Annual federal advocacy addresses access, insurance barriers, clean air, school nursing and public asthma programmes.
- Participation principle: the organization explicitly describes patients as experts in living with asthma and seeks their participation in research and policy.
- Sources: advocacy and public policy; Patient Advocacy Leadership Initiative; get involved (accessed 2026-08-30).
Global¶
Global Allergy & Airways Patient Platform (GAAPP)¶
- Role: international platform coordinating patient organizations across allergy and airway diseases.
- Patient support and voice: the “Define Your Asthma” campaign provides multilingual severe-asthma material derived from a survey conducted in four languages across 63 countries. It emphasizes individual variation, discussion with family, employers and clinicians, and the need to recognize asthma subtype and control.
- Funding transparency: the campaign page states that it was supported by GSK through agency support and an educational grant; that relationship should accompany reuse of campaign findings.
- Source: Support and advice for asthma (accessed 2026-08-30).
Coverage caveat¶
This is a verified, useful directory—not a census. English-language discovery and fetchability favour high-income-country organizations. Africa, South Asia, Latin America and much of continental Europe are under-represented, despite bearing substantial asthma morbidity and access barriers. The gap should be treated as missing coverage, not missing patient organization.